Issue Navigation
-
Review
-
62-73
Regulation of food intake and the development of anti-obesity drugs.
Chen Y
Drug Discov Ther. 2016; 10(2):62-73.
DOI: 10.5582/ddt.2016.01014
-
74-78
Yamada MK
Drug Discov Ther. 2016; 10(2):74-78.
DOI: 10.5582/ddt.2016.01003
-
79-81
Yamada MK
Drug Discov Ther. 2016; 10(2):79-81.
DOI: 10.5582/ddt.2016.01004
-
82-87
Tenascin C affects mineralization of SaOS2 osteoblast-like cells through matrix vesicles.
Li CZ, Cui YZ, Luan J, Zhou XY, Li HY, Wang HX, Shi L, Han JX
Drug Discov Ther. 2016; 10(2):82-87.
DOI: 10.5582/ddt.2016.01009
-
88-92
Wada Y, Ami S, Nozawa M, Goto M, Shimokawa K, Ishii F
Drug Discov Ther. 2016; 10(2):88-92.
DOI: 10.5582/ddt.2016.01019
-
93-102
Gambhir L
Drug Discov Ther. 2016; 10(2):93-102.
DOI: 10.5582/ddt.2016.01028
-
103-108
Chen HF, Zhang KJ, Wang S, Xu CX, Zou ZH, Tao AL
Drug Discov Ther. 2016; 10(2):103-108.
DOI: 10.5582/ddt.2016.01029
-
109-113
Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines.
Shirayama R, Shoji M, Sriwilaijaroen N, Hiramatsu H, Suzuki Y, Kuzuhara T
Drug Discov Ther. 2016; 10(2):109-113.
DOI: 10.5582/ddt.2016.01010
-
114-116
Hara N, Fujimoto N, Miyamoto Y, Yamagishi T, Asano M, Fuchimoto Y, Wada S, Ozaki S, Nishi H, Kishimoto T
Drug Discov Ther. 2016; 10(2):114-116.
DOI: 10.5582/ddt.2016.01005
-
117-122
Oya M, Takahashi T, Tanabe H, Oe M, Murayama R, Yabunaka K, Matsui Y, Sanada H
Drug Discov Ther. 2016; 10(2):117-122.
DOI: 10.5582/ddt.2016.01033